California Institute for Quantitative Biosciences Overview
- Investor Type
- Accelerator/Incubator
- Status
- Active
- Professionals
- 6
- Investments
- 412
- Portfolio
- 294
- Exits
- 113
California Institute for Quantitative Biosciences General Information
Description
Founded in 2000, California Institute for Quantitative Biosciences is an accelerator and incubator firm based in San Francisco, California.The firm seeks investments in acceleration and incubation, seed, and early stage companies. The firm prefers to make investments in bioeconomy sector.
Contact Information
Website
www.qb3.org
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Accelerator/Incubator
Other Investor Types
Venture Capital
VC-Backed Company
Primary Office
- Suite 214, Byers Hall
- UCSF Mission Bay, 1700 4th Street
- San Francisco, CA 94158
- United States
+1 (415) 000-0000
California Institute for Quantitative Biosciences Investments (412)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Xeno Biosciences | 01-Oct-2021 | Later Stage VC | 00.00 | Drug Discovery | Generating Revenue | |
| 0000000 (00000 000 | 10-Jun-2021 | 000000000000 | Other Devices and Supplies | Generating Revenue | ||
| 00000000 0000000 | 07-May-2021 | 00000 00000 | 00.00 | Monitoring Equipment | Startup | |
| 0000 0000 0000000 | 18-Dec-2020 | 00000 00000 | 00.00 | Surgical Devices | Generating Revenue | |
| 00000000 | 08-Nov-2019 | 000000000000 | Drug Discovery | Clinical Trials - General | 000000000 000000 | |
| 00000 (00000000000 | 08-Nov-2019 | 000000000000 | Biotechnology | Clinical Trials - Phase 1 | 000000000 000000 | |
| 0000000 | 21-Oct-2019 | 000000000000 | Drug Discovery | Generating Revenue | ||
| 00000000 | 23-Sep-2019 | 000000000000 | Other Commercial Services | Startup | ||
| Intact Therapeutics | 12-Jul-2019 | Accelerator/Incubator | Drug Delivery | Generating Revenue | ||
| Guided Clarity | 01-Jan-2019 | Accelerator/Incubator | Drug Discovery | Pre-Clinical Trials |
California Institute for Quantitative Biosciences Exits (113)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Z-Instruments | 04-Mar-2022 | Out of Business | |
| 000 00000000000 | 22-Dec-2021 | 000 00 00000000 | |
| 0000000 | 16-Dec-2021 | 000000000000000000 | 00000 |
| 0000 000000000000 | 13-Oct-2021 | 000 00 00000000 | |
| 000000 | 30-Sep-2021 | 000 00 00000000 | |
| 00000000 000000000 | 26-Aug-2021 | 0000000 000000 | 00000 |
| 000000 0000000 | 22-Aug-2021 | 000 00 00000000 | |
| 0000000 | 05-Aug-2021 | 000 00 00000000 | |
| Caribou Biosciences | 23-Jul-2021 | IPO | 00000 |
| Hex Labs | 28-May-2021 | Out of Business |
California Institute for Quantitative Biosciences Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialCalifornia Institute for Quantitative Biosciences Team (11)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Nevan Krogan Ph.D | Director | San Francisco, CA | |||
| Susan Marqusee Ph.D | Director | Berkeley, CA | |||
| Kaspar Mossman Ph.D | Director of Communications and Marketing | 0 | San Francisco, CA | ||
| David Haussler Ph.D | Director, QB3-UCSC; Scientific | Santa Cruz, CA | |||
| Regis Kelly Ph.D | Executive Director | 0 | San Francisco, CA |
California Institute for Quantitative Biosciences Co-Investors (26)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Band of Angels | 1 |
|
|
||
| HBM Healthcare Investments | 0 | 0 |
|
|
|
| Scop Venture Capital | 0 |
|
|
||
| Tech Coast Angels | 0 |
|
|
||
| Valor Equity Partners | 0 | 0 |
|
|